Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

242
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
242
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

338
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
338
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

249
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
249
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

RBMX functional retrocopy safeguards brain development in a species-dependent context.

Brain : a journal of neurology·2026
Same author

PMX-CovEval: A Framework Including a Simulated Pharmacokinetic Database for Covariate Model Building Methods Benchmarking.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Cdk7 promotes neuritogenesis in cortical neurons and contributes to social behavior in mice.

Cellular and molecular life sciences : CMLS·2026
Same author

Developmental gene expression patterns driving species-specific cortical features.

Nature·2026
Same author

Protocol for whole-cell patch-clamp recording and post hoc identification of hippocampal CA2 pyramidal neurons in adult mouse brain slices.

STAR protocols·2026
Same author

Sex Differences and Survival Among COPD Patients in France: The Palomb Cohort.

International journal of chronic obstructive pulmonary disease·2026

Video Experimental Relacionado

Updated: Jan 18, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K

Integración de enfoques poblacionales con modelos farmacocinéticos basados en fisiología: un marco novedoso para la

Donato Teutonico1, David Marchionni2, Marc Lavielle3,4

  • 1Pharmacometrics, Translational Medicine Unit, Sanofi, Vitry-sur-Seine, France.

CPT: pharmacometrics & systems pharmacology
|January 16, 2026
PubMed
Resumen

Este estudio presenta un nuevo método poblacional para modelos farmacocinéticos basados en fisiología (PBPK), que mejora la estimación de parámetros y reduce el tiempo de computación. El enfoque mejora el desarrollo de fármacos al aprovechar los datos individuales para predicciones farmacocinéticas más precisas.

Palabras clave:
PBPKSAEMvariabilidad individualfarmacocinética basada en fisiologíapopPBPKpopWB-PBPK

Más Videos Relacionados

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.3K
Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K

Videos de Experimentos Relacionados

Last Updated: Jan 18, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.3K
Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K

Área de la Ciencia:

  • Farmacocinética y Desarrollo de Fármacos
  • Biología Computacional y Bioinformática
  • Farmacología de Sistemas

Sus antecedentes:

  • El modelado farmacocinético basado en fisiología (PBPK) es crucial para predecir las concentraciones de fármacos durante el desarrollo.
  • La estimación de parámetros en modelos PBPK es un desafío debido a numerosos parámetros y datos limitados.
  • Los métodos existentes tienen dificultades para estimar de manera eficiente la variabilidad interindividual en parámetros fisiológicamente relevantes.

Objetivo del estudio:

  • Introducir un enfoque novedoso de modelado PBPK poblacional de todo el cuerpo (popWB-PBPK) para una estimación de parámetros mejorada.
  • Aprovechar los datos de pacientes individuales para una parametrización más precisa del modelo PBPK y la evaluación de la variabilidad.
  • Presentar un algoritmo optimizado de Aproximación Estocástica de Expectación-Maximización (SAEM) para una estimación eficiente de parámetros PBPK.

Principales métodos:

  • Acoplamiento de modelos PBPK de todo el cuerpo (WB-PBPK) con técnicas de estimación poblacional.
  • Implementación de un algoritmo SAEM optimizado con optimización adaptativa de la cuadrícula de parámetros e interpolación lineal.
  • Utilización de la teofilina como estudio de caso para estimar parámetros específicos del fármaco y efectos de covariables (por ejemplo, estado de fumador).

Principales resultados:

  • El enfoque popWB-PBPK estima con precisión parámetros específicos del fármaco como el aclaramiento de CYP1A2 y la lipofilicidad.
  • El algoritmo SAEM optimizado reduce significativamente el tiempo de computación en comparación con el SAEM estándar.
  • El método incorpora con éxito los efectos de los covariables, lo que demuestra su utilidad práctica.

Conclusiones:

  • El marco popWB-PBPK desarrollado proporciona un paquete R accesible (saemixPBPK) para una estimación robusta de parámetros PBPK.
  • Este enfoque permite la estimación simultánea de parámetros poblacionales, variabilidad e incertidumbre, preservando al mismo tiempo la relevancia fisiológica.
  • Los avances en el modelado mecanicista facilitan predicciones farmacocinéticas más confiables utilizando datos individuales.